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The subject of this thesis is the quality of glycohemoglobin assavs. The primary goal
is implovement of analytical qr.rality but the r-rltirnate scope is therapeutic amelioration
to prevent or delay krng term complications of diabetes mellitus.
Chapter 1, the general introduction, describes aspects of glvcohemoglobin ancl clualitv
assessntent. Clycohemoglobin u,as discor,ered by charrce in the fifties and has, once its
application had become clearr, developed to an important assay in the clinical chemical
laboratorv (in The Netherlands an annual number of 1 mill ion assays is estimated).
There has been a frecl-rent change in nomenclzrture; since 1986 tlre officially recornmen-
ded name is glycohernogiobin Lrut the trivini "FIbA1." is still in common nse-. From bio-
chemical point of view glycohernoglobin is a condensation product of hemoglobin and
glucose. Glucose can react with several amino-groups in the hemoglobin moiecule but
the major part (60%,) of glycohenroglobin is formed at the valine N-terminal of the B-
chair"r and gives rise to HbAr.. Measrtrement of glycohemoglobin irrdicates mean blood
glucose concentratiolrs in the preceeding months and is as such a valuable tocrl to assess
the effect of efforts to achieve diirbetic control. Assay-results vary per laboratory. This is
caused by the nurnerous analytical methods, by methoc{-specific clmplications and by
lack of stanclardization. Standardizirt ion of irnalvtical resr-rlts is a plt.requisitc for opti-
munr c l i r r ica l  use oí  g lycohemt,g lobin.  External  qual i t r  orr " r r -* , ' , i  is  1.s .1 o i  t l rc  in tegr-
a1 quality system of the clinical chemical laboratory which is derived from tl.re quality
policy in l'realth care and society in general. The MCA-section of tlie SKZL is in charge
rt'ith external quality ;rssessment clf non-rotrtine assays. The MCA-n-rodel consists of 3
essentiai cicments: home-macle samples, a design to measure accuracy antl precisior.r
with options tcl investigate l inearity, artefacts and cases, and feedlrack to the participa-
ting laboratories. In this thesis the MCA moclel is applied to glycohemoglobin.
Chapter 2 clescribes ollrces oi irnalytical virri irt ion and ho\\ ' they can be l imited Lri '
standarcliza tion.
Chapter 2.1 describes the analytical perfomrance at the beginning of this studv. Stable
lyophil izecl ethylene dizrmine tetrtr acetic acicl (EDTA)-blood hemolysirtes were:rprplied
in an external quality assurallce progran (SKZL, The Netherlancls) for glycohemoglo-
bin assays in 101 laboratories using 12 methods. The mean intralaboratory day-to-da1,
coefficient of variation (CV), calculated from the assay of 12 unidentif ied pairs over .l
period of 1 year, was 5.2'X, (range: 0.2-28.7). Forty-seven per cent of lal.roratories clid not
n.reet the criterion of CV<59i, u,ltereas 6ti'2, did not ineet tl-re clinically more desirable
3.3-3.6"/,,. Linearity, as derived from the analysis of five combinatiorrs of tr,r''c'r hemolvsa-
tes with low and high glycohemoglobin percentages over 6 months, was excellent
(mean correiation coefficient 0.9953; range 0.-c)188-0.91)99). Analysis of two samples with
high and lolv glvcoher-noglobin percentaEies gave mean irrtcrlaboratory coefficier-its oi
variation of 10"/o for one method performed by several laboratories and 22"1' for all
methods performecl by all laboratoiies. It was cóncluded that interlabclratory variation
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due to intermethod variation was the major source of analytical variation and that stan-
clardization by calibration could ameliorate this situation.
Chapter 2.2 deals with the properties of a lyophilized reference material. A candidate
reference material for the assay of glycohemoglobin was investigated in respect to IFCC
recommendations for calibration and control matelials. When stored at 4'C the stabilitv
is 1 year for HPLC application and 5 years for use with affinity chromatography, elec-
trophoresis and imrnuno assay. Storage at -20"C or below gives stability for at least 5
years for all methods. In its reconstituted form and stored at 4"C the reference material
was stable for 2 days with HPLC ancl for 7 days with other methocls. Matrix effects of
the reference material r.t'ere investigated by comparisorr of glycohemoglobin percenta-
ges in lyophilized and whole blood, which demonstrated differences of Iess than 0.2'lo
as detelrninecl by HPLC, electrophoresis, affinity chromatop;raphy and immrlnoassay. A
CV of 0.59% for the filling precision and an equal reproducibility of assays in whole
and lyc'rphilized blood by 4 methods showed an acceptalrle hornogeneity.
In chapter 2.3 the lyophilized reference material is used as a calibrator. One hundred
eleven laboratories, using 21 methods based on five different principles, determined
glycohemoglobin percentages in two identical series of six lyophiiized hernolysates and
three sir-nilarly processed calibrators, distributed 3 months aprart. To assign glycohe-
rnoglobin percentages to calibrators, we used I{bAl. resr-rlts from nine participants who
r-rsed the Bio-Rad Diamat high performance liqr-rid chromatographic method. Three-
point calibrartion r,vith assigned values improved mean intrirlaboratory variation (CV)
from 6.6%' to 3.5'lo. For samples with low (5,5%,) and high (14.1"1,) glycohemoglobin per-
centages, respectively, calibration decreased interlaboratory variation per metirod (frorn
10% to 4'Á and from 6ok to 3%), intermethod variation (from 18'lu to 4'lo and from 16%
to 3'lo), and overall interlaboratory variation (fron'r 25%, to 7"/" and from 15'lo to 4"/o).
Without calibration, 7\% of the laboratories did not meet the clinically desirable intrala-
boratory CV of 3.5')'i,; calibratiorr reduced this prop'rortion to 39%,. We conclude that, irre.-
spective of the analytical method used, calibration greatly reduces all sources of glyco-
hemogiobin variation.
Chaper 2.4 is ar-r extension of 2.3. The rnajor limitation of that study was that it repor-
ted the effect of l1'ophilized calibrators on the dispersion of glycohemoglobin results
that were obtained from lyophilized samples. This chapter describes the effect of lyop-
hilized caliblators on whole-blood glycohemoglobin results. One hundred three labora-
tories, using 20 different methods, deterrnined glycohemoglobin in trt'o lyophilized
calibrators and two whole-bloocl samples. For whole-blood samples with low (5o1,) and
high (9%) glycol'remoglobin percentages, respectively, calibration decreased overall
interlaboratory variation (CV) from 1,6"/o to 9('/o and from 11% to 6% and decreased
internrethod variation from 14'lo to 6(/o ancl Íron 12nl' to 57,. Fortv-seveu laboratories,
r,rsing 14 different methods, determined mean glycohemoglobin percentages in self-
.selected grollps of 10 non-diabetic volunteers each. With calil'rration their overail mean
(2SD) n'as 5.0"1' (0.5"1,), very close to the 5.0% (0.3%) derived from the reference method
used in the Diabetes Control and Complications Trial. In both experiments the Abbott
IMx and Vision showed deviating results. We conclude that, irrespective of the analyti-






















































































rence values, and interpretation criteria.
Chiipter' 3 describes the influence of stmctural and post-translatioual hernoglobin
rrariants on the result of glycohemoglobin measurements.
Chapter 3.1 deals with the interference of carbamylated and acetylated hemoglobirr in
assays of glycohemoglobin by HPLC, electrophoresis, affinity chrornatographv, and
enzyme immunoassay. Invitro synthesized carbamylated and acetylated hemoglobins
interferecl in assays of glycohemoglobin by HPLC and electrophoresis but had ncr
r'ffects on results obtained by affinity chror.natography ar-rd enzynre immunoassay.
Correlations betrveen long-term serum urea concentrations and glycohemoglobin per-
centages revealed that, in vivo, carbamylated hemoglobin equirralent to 0.063'2, of total
hemogkrbin is forrned for every 1 rnrnol/L clf serum urea. The use of acetylsalicylate,
either chronicallv in small doses (200-300 mg/day), or for 1 lveek at 2000 mglday, did
not cause significant interi:erence from acetylhernoglobin, formed in vivo. We conclude
that interference from carbamylated hemoglobin explains only er small part of existing
clisclepancies between results of glvcohemoglobin assays in current use. The interÍering
effect of acetylhemoglobin formed in vivo with acetyl-CoA as substrate is as yet unk-
nown.
Chaper 3.2 shorvs the effect of vitamin C on results of glycohemoglobin assays. Three
groups of 10 age- and sex matched non-diabetic volunteers took 0, 750 and 1500 mg
vitamir-r C/day, respectively, during 12 weeks. Glycohemoglol.rin was measurecl by
HPLC, electrophoresis, affinity cirromatography and immunoassay at baseline (- 4
weeks arld - 1 day), during sr-rpplementation (6 and 12 weeks) and after supplementa-
tion (6 and 12 weeks). Plasma vitamin C doubled during supplementation. There were
r1o betn'een-group differences in glvcohemoglobin, glucose and fructosamine.
Fructosamine may have increased lvith storage time. Net effects of vitarnin C on abso-
lute glycohemoglobin [12 weeks vs - 1 day (12 weeks vs 12 weeks after); in % CFIb]
amountecl to: HPLC - 0.035 (-0.050); electrophoresis + 0.005 (+0.035); affinity chromato-
grapirv - 0.070 (+0.015); and imrnunoassay - 0.110 (+0.025). l lesults contrasted with
those of Davie et al (Diabetes 1992;4I1,67-73). The conclusion was that supplementation
of non-diabetics with 3x250 or 3x500 mg vitamin C/day during 12 u'eeks does not
cause interference it1 glvcohernoglobin by HPLC, electrophoresis, affinity chromatogra-
phy and immunoassay, and that it does not reduce in r.'ivo hemoglobin glycation.
In chapter 3.3 the infiuence of stmctural hemoglobirr variants and four derivrrtives
(post-trtrnslational variants) on 5;lycohemoglobin determinations is investigated.
Influences of hemoglobin variants (HbSS, HbCC, B-thaiassemia, HbAE, tIbAS, HbAC,
hereditary persistent FIbF) and FIb derivatives (carbamylated- and acetylated- Hbs,
Schiff base, and those formed in stored blood) on results of glycohemoglobirr assays by
102 laboratories using 16 different methods were investigatecl. Affinitr. chromatogra-
phy shows deviating results only with homozygous hemoglobin S and C. Correct inter-
pretation of results from pzrtients u'ith decreased erythrocyte l-rirlf-lives requires pre-
vious knowledge of this condition. Measurements of HbA1. by HPLC ancl electrophore-
sis are obviously unsuitable for homozygoris hemoglobinopathies; fclr heterozygous
hemoglobinopathies and hemoglobin synthesis variants, HbA1. should be expressed as
r37
percentelge of HbA., + FIbA1.; abnonlal hemoglobins are usually recognized; both car-
barnylated and acetylated hernoglobins interfere, and Schiff base must be eliminated.
Except for stored blood, all hemoglobir-r variants and derivatives gave erroneous results
with disposable ion-excl-range columns. DAKO's immunoassay is not affected by
irernoglobin derivatives; glycated hemoglobin variants are not recognized as glycohe-
rnoglobin ancl percentages are consecl-rently too low. Glycohemoglobin by the imrnuno-
assay of Bayer (perfonled by one laboratory) is not affected by heinoglobin variants
and derivatir,'es. The conclLrsion was that ar vari;rble, method-specific influence exists
ancl that tl-re prevarlence of the respecti."'e henroglobin variants'.rnd derivatives in the
adherent popr-rlation should be taken into account wherr choosing a method.
h'r chapte.r 3.4 it is demonstrated that the use of adjusted ret'erence values can com-
pellsate the effect of hemoglobin variants S and C on the result of glycohernogiobin
determinations of specific methods. Clycohemoglobin reference ranges clf non-diabetic
adults with HbAA (=17), HbAS (n=37), HbAC (n=22), HbSC (r'L=E), HbSS (n=6) and
HbCC (n=3) w'ere cietenniued by 13 methods, based on affinity chrornatography,
HPLC, electrclphoresis and irnmunoassay. Glycohemogkrbin in subjects r'r'ith ÉIbAS and
HbAC can be measurecl without rnajor difficulties by most methods. Some give rise to
absoh-rti' glycol'rernoglobin differences ) 1'% compared r'vith sr-rbjects n,ith HbAA.
Measurements of HbAl./tottrl Hb cannot be recornmended. Some HPLC and immuno-
assay methods cannot lneasure glycohemoglobin in subjects with HbSC, HbSS and
HbCC, whereas clthers may suffer frcln'r interference. Most methods showed iow giyco-
hemogiobin, reflectirrg increased erythrocyte turnover. Use of special reference ranges
requires previor-rs knowledge of the condition (affinity chromatography and immuno-
assay) or separation of glycohemoglobin and its precursor Hb (HPLC arnd electrophore-
sis). Interpretation is, however, not recommended because of the numerous factors that
determine ervthrocyte turnover.
Chapter 4 consiclers whether the aim of the thesis has been achieved. In an objective
and efficient way tl-re MCA-model contributed to gaining and proliferating knowledge
to improve tire quality of glycohemoglobin assays. The analytical qualitv, e-xpressed as
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